Logo image of CERT

CERTARA INC (CERT) Stock Fundamental Analysis

NASDAQ:CERT - Nasdaq - US15687V1098 - Common Stock - Currency: USD

11.4  +0.47 (+4.3%)

Premarket: 11.43 +0.03 (+0.26%)

Fundamental Rating

4

CERT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 36 industry peers in the Health Care Technology industry. CERT has an average financial health and profitability rating. CERT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CERT was profitable.
In the past year CERT had a positive cash flow from operations.
CERT had negative earnings in 4 of the past 5 years.
CERT had a positive operating cash flow in each of the past 5 years.
CERT Yearly Net Income VS EBIT VS OCF VS FCFCERT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

CERT's Return On Assets of -0.17% is amongst the best of the industry. CERT outperforms 83.33% of its industry peers.
CERT's Return On Equity of -0.24% is amongst the best of the industry. CERT outperforms 83.33% of its industry peers.
With a decent Return On Invested Capital value of 0.39%, CERT is doing good in the industry, outperforming 69.44% of the companies in the same industry.
Industry RankSector Rank
ROA -0.17%
ROE -0.24%
ROIC 0.39%
ROA(3y)-1.12%
ROA(5y)-1.63%
ROE(3y)-1.69%
ROE(5y)-2.47%
ROIC(3y)N/A
ROIC(5y)N/A
CERT Yearly ROA, ROE, ROICCERT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6

1.3 Margins

With a decent Operating Margin value of 1.82%, CERT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 60.26%, CERT is in line with its industry, outperforming 52.78% of the companies in the same industry.
CERT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.82%
PM (TTM) N/A
GM 60.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-0.61%
CERT Yearly Profit, Operating, Gross MarginsCERT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CERT is destroying value.
Compared to 1 year ago, CERT has more shares outstanding
The number of shares outstanding for CERT has been increased compared to 5 years ago.
The debt/assets ratio for CERT is higher compared to a year ago.
CERT Yearly Shares OutstandingCERT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CERT Yearly Total Debt VS Total AssetsCERT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.63 indicates that CERT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CERT's Altman-Z score of 2.63 is fine compared to the rest of the industry. CERT outperforms 69.44% of its industry peers.
The Debt to FCF ratio of CERT is 4.19, which is a neutral value as it means it would take CERT, 4.19 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.19, CERT is doing good in the industry, outperforming 72.22% of the companies in the same industry.
A Debt/Equity ratio of 0.27 indicates that CERT is not too dependend on debt financing.
CERT's Debt to Equity ratio of 0.27 is in line compared to the rest of the industry. CERT outperforms 41.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 4.19
Altman-Z 2.63
ROIC/WACC0.04
WACC10.59%
CERT Yearly LT Debt VS Equity VS FCFCERT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.78 indicates that CERT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.78, CERT is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
CERT has a Quick Ratio of 2.78. This indicates that CERT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CERT (2.78) is better than 63.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 2.78
CERT Yearly Current Assets VS Current LiabilitesCERT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

CERT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
The Earnings Per Share has been growing by 38.33% on average over the past years. This is a very strong growth
The Revenue has grown by 9.37% in the past year. This is quite good.
CERT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.06% yearly.
EPS 1Y (TTM)16.67%
EPS 3Y38.33%
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)9.37%
Revenue growth 3Y10.42%
Revenue growth 5Y13.06%
Sales Q2Q%9.67%

3.2 Future

The Earnings Per Share is expected to grow by 16.82% on average over the next years. This is quite good.
Based on estimates for the next years, CERT will show a quite strong growth in Revenue. The Revenue will grow by 8.25% on average per year.
EPS Next Y5.46%
EPS Next 2Y11.46%
EPS Next 3Y11.42%
EPS Next 5Y16.82%
Revenue Next Year9.77%
Revenue Next 2Y9.35%
Revenue Next 3Y9.57%
Revenue Next 5Y8.25%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CERT Yearly Revenue VS EstimatesCERT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CERT Yearly EPS VS EstimatesCERT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.27, CERT is valued on the expensive side.
Based on the Price/Earnings ratio, CERT is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CERT is valued at the same level.
A Price/Forward Earnings ratio of 20.39 indicates a rather expensive valuation of CERT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CERT indicates a rather cheap valuation: CERT is cheaper than 80.56% of the companies listed in the same industry.
CERT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 23.27
Fwd PE 20.39
CERT Price Earnings VS Forward Price EarningsCERT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CERT indicates a somewhat cheap valuation: CERT is cheaper than 75.00% of the companies listed in the same industry.
83.33% of the companies in the same industry are more expensive than CERT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 26.31
EV/EBITDA 25.39
CERT Per share dataCERT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.26
PEG (5Y)N/A
EPS Next 2Y11.46%
EPS Next 3Y11.42%

0

5. Dividend

5.1 Amount

No dividends for CERT!.
Industry RankSector Rank
Dividend Yield N/A

CERTARA INC

NASDAQ:CERT (7/8/2025, 8:11:58 PM)

Premarket: 11.43 +0.03 (+0.26%)

11.4

+0.47 (+4.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners78.35%
Inst Owner Change-0.04%
Ins Owners2.43%
Ins Owner Change3.31%
Market Cap1.85B
Analysts75.29
Price Target16.09 (41.14%)
Short Float %7.36%
Short Ratio4.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.78%
Min EPS beat(2)15.79%
Max EPS beat(2)23.76%
EPS beat(4)3
Avg EPS beat(4)5.46%
Min EPS beat(4)-33.58%
Max EPS beat(4)23.76%
EPS beat(8)3
Avg EPS beat(8)-0.71%
EPS beat(12)4
Avg EPS beat(12)-0.91%
EPS beat(16)6
Avg EPS beat(16)-6.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.46%
Min Revenue beat(2)-0.91%
Max Revenue beat(2)0%
Revenue beat(4)1
Avg Revenue beat(4)-2.08%
Min Revenue beat(4)-4.75%
Max Revenue beat(4)0%
Revenue beat(8)2
Avg Revenue beat(8)-1.75%
Revenue beat(12)4
Avg Revenue beat(12)-1.41%
Revenue beat(16)5
Avg Revenue beat(16)-1.85%
PT rev (1m)2.16%
PT rev (3m)9.23%
EPS NQ rev (1m)-1.32%
EPS NQ rev (3m)-5.44%
EPS NY rev (1m)2.53%
EPS NY rev (3m)1.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 23.27
Fwd PE 20.39
P/S 4.69
P/FCF 26.31
P/OCF 19.78
P/B 1.71
P/tB N/A
EV/EBITDA 25.39
EPS(TTM)0.49
EY4.3%
EPS(NY)0.56
Fwd EY4.9%
FCF(TTM)0.43
FCFY3.8%
OCF(TTM)0.58
OCFY5.06%
SpS2.43
BVpS6.68
TBVpS-0.96
PEG (NY)4.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -0.24%
ROCE 0.49%
ROIC 0.39%
ROICexc 0.45%
ROICexgc 16.63%
OM 1.82%
PM (TTM) N/A
GM 60.26%
FCFM 17.82%
ROA(3y)-1.12%
ROA(5y)-1.63%
ROE(3y)-1.69%
ROE(5y)-2.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-0.61%
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 4.19
Debt/EBITDA 3.77
Cap/Depr 33.09%
Cap/Sales 5.89%
Interest Coverage 0.33
Cash Conversion 120.83%
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 2.78
Altman-Z 2.63
F-Score5
WACC10.59%
ROIC/WACC0.04
Cap/Depr(3y)27.38%
Cap/Depr(5y)24.09%
Cap/Sales(3y)4.51%
Cap/Sales(5y)3.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y38.33%
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y5.46%
EPS Next 2Y11.46%
EPS Next 3Y11.42%
EPS Next 5Y16.82%
Revenue 1Y (TTM)9.37%
Revenue growth 3Y10.42%
Revenue growth 5Y13.06%
Sales Q2Q%9.67%
Revenue Next Year9.77%
Revenue Next 2Y9.35%
Revenue Next 3Y9.57%
Revenue Next 5Y8.25%
EBIT growth 1Y385.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.49%
EBIT Next 3Y12.31%
EBIT Next 5Y14.24%
FCF growth 1Y-12.29%
FCF growth 3Y4.89%
FCF growth 5Y15.82%
OCF growth 1Y0.89%
OCF growth 3Y10.04%
OCF growth 5Y16.17%